Estudio descriptivo retrospectivo y analítico de las leucemias agudas promielociticas diagnosticadas en el servicio de hematología del hospital Maciel e incluidas en el protocolo Pethema en el período noviembre 2002- noviembre 2013

Montes de Oca, Catalina.
Montevideo; s.n; 2015. 39 p. tab, graf.
Tesis en Español | BVSNACUY | ID: bnu-180967

Documentos relacionados

  1. Modulation of CD47-SIRPα innate immune checkpoint axis with Fc-function detuned anti-CD47 therapeutic antibody.
  2. HLA-DR antigen-positive acute promyelocytic leukemia.
  3. [Association of CD34 cell surface antigen expression with cytomorphological characteristics of acute promyelocytic leukemia blasts and clinical characteristics of patients: one center experience].
  4. Interleukin-10 and interferon-gamma up-regulate the expression of B-cell activating factor in cultured human promyelocytic leukemia cells.
  5. An Atypical PML-RARA Rearrangement Resulting from Submicroscopic Insertion of the RARA Gene at the PML Locus with Novel Breakpoints within PML Exon 7b and RARA Exon 3.
  6. Angiogenesis, coagulation, and fibrinolytic markers in acute promyelocytic leukemia (NB4): An evaluation of melatonin effects.
  7. STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells.
  8. A microgranular variant of acute promyelocytic leukemia with atypical morpho-cytochemical features and an early myeloid immunophenotype.
  9. ZBTB16::RARA variant acute promyelocytic leukemia (vAPL) treated with gemtuzumab ozogamicin (GO) with unique pathology and genetic findings.
  10. Expression and secretion of galectin-12 in the context of neutrophilic differentiation of human promyeloblastic HL-60 cells.